Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Wen-Ying Liao"'
Autor:
Chiao-Yun Pan, Keng-Wei Liang, Ting-Rong Chen, Chien-Kuo Wang, Wen-Ying Liao, Ying-Hung Lu, Yi-Cheng Hsiung, Yi-Sheng Liu, Bow Wang
Publikováno v:
Frontiers in Medicine, Vol 11 (2024)
BackgroundTransarterial microembolization (TAME) is a minimally invasive treatment for chronic musculoskeletal disorders. Identifying angiogenesis and the supplying vessels of the target joint is important but challenging. Although magnetic resonance
Externí odkaz:
https://doaj.org/article/7252d4af522440628117cf5b1d23dd05
Autor:
Wen-Ying Liao, Chung-Chi Hsu, Tze-Sian Chan, Chia-Jui Yen, Wei-Yu Chen, Hung-Wei Pan, Kelvin K. Tsai
Publikováno v:
Stem Cell Reports, Vol 14, Iss 3, Pp 462-477 (2020)
Summary: Various populations of cancer stem cells (CSCs) have been identified in hepatocellular carcinoma (HCC). Wnt signaling is variably activated in HCC and regulates CSCs and tumorigenesis. We explored cell-to-cell Wnt and stemness heterogeneity
Externí odkaz:
https://doaj.org/article/1424c1640622477d9db3d11114a2ae15
Autor:
Shenq-Shyang Huang, Wen-Ying Liao, Chung-Chi Hsu, Tze-Sian Chan, Tai-Yan Liao, Pei-Ming Yang, Li-Tzong Chen, Shian-Ying Sung, Kelvin K. Tsai
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Externí odkaz:
https://doaj.org/article/0ee3b4985b4a406db566d707f284a2bc
Autor:
Shenq-Shyang Huang, Wen-Ying Liao, Chung-Chi Hsu, Tze-Sian Chan, Tai-Yan Liao, Pei-Ming Yang, Li-Tzong Chen, Shian-Ying Sung, Kelvin K. Tsai
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionStem-like cancer cells or cancer stem cells (CSCs) may comprise a phenotypically and functionally heterogeneous subset of cells, whereas the molecular markers reflecting this CSC hierarchy remain elusive. The glycolytic enzyme alpha-enola
Externí odkaz:
https://doaj.org/article/fe1df7fbf0ab4bdf93b90ac6b446789c
ASPM Activates Hedgehog and Wnt Signaling to Promote Small Cell Lung Cancer Stemness and Progression
Autor:
Li-Hsin Cheng, Chung-Chi Hsu, Hung-Wen Tsai, Wen-Ying Liao, Pei-Ming Yang, Tai-Yan Liao, Hsiao-Yen Hsieh, Tze-Sian Chan, Kelvin K. Tsai
Publikováno v:
Cancer Research. 83:830-844
Small cell lung cancer (SCLC) is among the most aggressive and lethal human malignancies. Most patients with SCLC who initially respond to chemotherapy develop disease relapse. Therefore, there is a pressing need to identify novel driver mechanisms o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4ea593fb383eac6637f05794a71aa543
https://doi.org/10.1158/0008-5472.can-22-2496
https://doi.org/10.1158/0008-5472.can-22-2496
Publikováno v:
Journal of Cancer Research and Practice, Vol 4, Iss 4, Pp 123-126 (2017)
Metronomic chemotherapy involves the administration of cytotoxic chemotherapy at reduced doses administered at regular and frequent intervals. Low-dose metronomic (LDM) chemotherapy represents an alternative to standard maximum tolerated dose (MTD) c
Externí odkaz:
https://doaj.org/article/5354c0492e0e4c9db4bf229462b90932
Autor:
Kelvin K. Tsai, Tze-Sian Chan, Hsiao-Yen Hsieh, Tai-Yan Liao, Pei-Ming Yang, Wen-Ying Liao, Hung-Wen Tsai, Chung-Chi Hsu, Li-Hsin Cheng
This file contains Supplementary figures S1-S6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41993063726607022156b8bc16aa73e7
https://doi.org/10.1158/0008-5472.22433250
https://doi.org/10.1158/0008-5472.22433250
Autor:
Kelvin K. Tsai, Tze-Sian Chan, Hsiao-Yen Hsieh, Tai-Yan Liao, Pei-Ming Yang, Wen-Ying Liao, Hung-Wen Tsai, Chung-Chi Hsu, Li-Hsin Cheng
This file contains Supplementary Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e6b1d57f6ad51c22df774a343b64e69
https://doi.org/10.1158/0008-5472.22433247.v1
https://doi.org/10.1158/0008-5472.22433247.v1
Autor:
Kelvin K. Tsai, Tze-Sian Chan, Hsiao-Yen Hsieh, Tai-Yan Liao, Pei-Ming Yang, Wen-Ying Liao, Hung-Wen Tsai, Chung-Chi Hsu, Li-Hsin Cheng
Small cell lung cancer (SCLC) is among the most aggressive and lethal human malignancies. Most patients with SCLC who initially respond to chemotherapy develop disease relapse. Therefore, there is a pressing need to identify novel driver mechanisms o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4cbae0d39333cd7373121fe187841c
https://doi.org/10.1158/0008-5472.c.6514326
https://doi.org/10.1158/0008-5472.c.6514326
Autor:
Kelvin K. Tsai, Shenq-Shyang Huang, Jason J. Northey, Wen-Ying Liao, Chung-Chi Hsu, Li-Hsin Cheng, Michael E. Werner, Chih-Pin Chuu, Chandrima Chatterjee, Jonathon N. Lakins, Valerie M. Weaver
Publikováno v:
Nature cancer, vol 3, iss 6
Resistance to antitumor treatment contributes to patient mortality. Functional proteomic screening of organoids derived from chemotherapy-treated patients with breast cancer identified nuclear receptor corepressor 2 (NCOR2) histone deacetylase as an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6ffd4ae59aba35ebb6ba5ea2a63e7e9
https://escholarship.org/uc/item/2b76h4b8
https://escholarship.org/uc/item/2b76h4b8